Published 18 days ago

Vaccine Safety and DMT for Highly Active Multiple Sclerosis: New Data

Summary by Medscape

Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary. Medscape Medical News

0 Articles

All

Left

Center

Right

Medscape

Vaccine Safety and DMT for Highly Active Multiple Sclerosis: New Data

Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary. Medscape Medical News

18 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.